|
Montoro-García S, Shantsila E, Tapp LD, López-Cuenca A, Romero AI, Hernández-Romero D, Orenes-Piñero E, Manzano-Fernández S, Valdés M, Marín F, Lip GY. Small-size circulating microparticles in acute coronary syndromes: relevance to fibrinolytic status, reparative markers and outcomes. Atherosclerosis. 2013 Apr;227(2):313-22. doi: 10.1016/j.atherosclerosis.2013.01.028. PubMed PMID: 23415055.
AÑO: 2013; IF: 3.971
|
23415055
|
Orenes-Piñero E, Manzano-Fernández S, López-Cuenca Á, Marín F, Valdés M, Januzzi JL. ?-Trace protein: from GFR marker to cardiovascular risk predictor. Clin J Am Soc Nephrol. 2013 May;8(5):873-81. doi: 10.2215/CJN.08870812. Review. PubMed PMID: 23335042.
AÑO: 2013; IF: 5.25
|
|
Roldán V, Marín F, Manzano-Fernández S, Gallego P, Vílchez JA, Valdés M, Vicente V, Lip GY. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol. 2013 Dec 10;62(23):2199-204. doi: 10.1016/j.jacc.2013.08.1623. PubMed PMID: 24055744.
AÑO: 2013; IF: 15.343
|
|
Vílchez JA, Roldán V, Manzano-Fernández S, Fernández H, Avilés-Plaza F, Martínez-Hernández P, Vicente V, Valdés M, Marín F, Lip GY. ?-Trace protein and prognosis in patients with atrial fibrillation receiving anticoagulation treatment. Chest. 2013 Nov;144(5):1564-70. doi: 10.1378/chest.13-0922. PubMed PMID: 23975142.
AÑO: 2013; IF: 7.132
|
|
Roldán V, Marín F, Manzano-Fernandez S, Fernández H, Gallego P, Valdés M, Vicente V, Lip GY. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation? Thromb Haemost. 2013 May;109(5):956-60. doi: 10.1160/TH13-01-0054. PubMed PMID: 23572113.
AÑO: 2013; IF: 5.76
|